NGNE Wutah dodolan triwulanan neurogene.com

Simbol resmi perusahaan Neurogene (NGNE)

Neurogene Inc. bases its future revenues on the commercialization of gene therapies for rare nervous system pathologies. The quarterly sales growth rate on the GURU.Markets consolidated chart clearly demonstrates a trend where 0.00 records a new level. However, the risk of clinical trial failure and a narrow target market create threats, while the lack of profit coupled with high R&D expenditures necessitates strict cash control.

NGNE (Neurogene Corp) riwayat Tingkat wutah dodolan sajrone kuartal saka 21.02.2024 nganti 20.11.2026

NGNE (Neurogene Corp): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:NGNE - Neurogene
Produk sing diprodhuksi Neurogene Inc

Neurogene Inc. focuses on developing gene therapies for rare pathologies and is currently in an intensive research stage without commercial sales. By analyzing the relative quarterly revenue change, an investor assesses the dynamics of incoming cash flows from core operations. This metric is calculated as the percentage deviation of current sales volume from the same period last year. The lack of growth confirms the business's R&D status and the risk of increasing capital expenditures.

Pesaing langsung

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|Annexon (ANNX) - Tingkat wutah pendapatan sajrone kuartal|OMER - Wutah pendapatan kuartal marang kuartal|ACIU - Wutah pendapatan triwulanan|Voyager Corp (VYGR) - Wutah pendapatan kuartal marang kuartal|NMRA - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Scilex|TVGN (Tevogen Bio) - Owah-owahan dodolan kuartal marang kuartal|Wutah dodolan triwulanan ACOG (alphacognition.com)|Tingkat wutah dodolan sajrone kuartal Cognition Therapeutics, Inc.|Wutah pendapatan triwulanan IKT (Inhibikase Pharma)|Wutah pendapatan triwulanan Cassava Sciences, Inc. SAVA|ASRT - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Wutah pendapatan kuartal marang kuartal|OVID - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Acumen Pharmaceuticals, Inc|Wutah pendapatan kuartal marang kuartal CRVO|Wutah pendapatan triwulanan ATHE|Clene - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PEPG (pepgen.com)|JUNS: Wutah dodolan kuartal marang kuartal|RLMD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Firefly Neuroscience (AIFF)|Wutah dodolan triwulanan KLTO|NRSN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Reviva Pharmaceuticals Holdings (RVPH)|Wutah dodolan triwulanan MetaVia, Inc. MTVA|Wutah pendapatan kuartal marang kuartal NeurAxis NRXS|HSDT: Wutah dodolan kuartal marang kuartal|passagebio.com - Wutah pendapatan triwulanan|NEUP - Wutah pendapatan triwulanan|Minerva Neurosciences Corp (NERV) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ALZN (Alzamend Neuro)|Wutah pendapatan kuartal marang kuartal Cyclerion Therapeutics Inc. (CYCN)|Wutah pendapatan triwulanan Protagenic Therapeutics, Inc. (PTIX)|Wutah pendapatan triwulanan KTTA (Pasithea Therapeutics Corp)|CRGT - Wutah dodolan triwulanan|ATXI - Wutah pendapatan kuartal marang kuartal|BCLI: Wutah pendapatan kuartal marang kuartal|Cara Therapeutics (CARA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Chromocell Therapeutics Corp (CHRO)|Wutah dodolan triwulanan ELYM|Tingkat wutah pendapatan sajrone kuartal intracellulartherapies.com ITCI|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal